These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
391 related items for PubMed ID: 9815651
1. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC. Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651 [Abstract] [Full Text] [Related]
4. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression. Kakolyris S, Giatromanolaki A, Koukourakis M, Leigh IM, Georgoulias V, Kanavaros P, Sivridis E, Gatter KC, Harris AL. Cancer Res; 1999 Nov 01; 59(21):5602-7. PubMed ID: 10554041 [Abstract] [Full Text] [Related]
10. Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer. Giatromanolaki A, Koukourakis MI, Kakolyris S, Kaklamanis L, Barbatis K, O'Byrne KJ, Theodosssiou D, Harris AL, Gatter KC. Anticancer Res; 1998 Jun 01; 18(1A):71-6. PubMed ID: 9568058 [Abstract] [Full Text] [Related]
11. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer. Aikawa H, Takahashi H, Fujimura S, Sato M, Endo C, Sakurada A, Kondo T, Tanita T, Matsumura Y, Ono S, Saito Y, Sagawa M. Anticancer Res; 1999 Jun 01; 19(5B):4305-9. PubMed ID: 10628391 [Abstract] [Full Text] [Related]
12. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Fontanini G, Vignati S, Boldrini L, Chinè S, Silvestri V, Lucchi M, Mussi A, Angeletti CA, Bevilacqua G. Clin Cancer Res; 1997 Jun 01; 3(6):861-5. PubMed ID: 9815760 [Abstract] [Full Text] [Related]
15. Prognostic significance of microvascularization in cases of operated lung cancer. Szöke T, Kayser K, Baumhäkel JD, Trojan I, Furak J, Tiszlavicz L, Eller J, Boda K. Eur J Cardiothorac Surg; 2005 Jun 01; 27(6):1106-11. PubMed ID: 15896626 [Abstract] [Full Text] [Related]
16. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer. Iwasaki T, Nakagawa K, Nakamura H, Takada Y, Matsui K, Kawahara K. Oncol Rep; 2005 Jun 01; 13(6):1075-80. PubMed ID: 15870924 [Abstract] [Full Text] [Related]
17. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Harpole DH, Richards WG, Herndon JE, Sugarbaker DJ. Ann Thorac Surg; 1996 May 01; 61(5):1470-6. PubMed ID: 8633961 [Abstract] [Full Text] [Related]
18. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. Shang ZJ, Li JR. J Oral Pathol Med; 2005 Mar 01; 34(3):134-9. PubMed ID: 15689226 [Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC. Clin Cancer Res; 1998 Dec 01; 4(12):3017-24. PubMed ID: 9865915 [Abstract] [Full Text] [Related]
20. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Chen JJ, Yao PL, Yuan A, Hong TM, Shun CT, Kuo ML, Lee YC, Yang PC. Clin Cancer Res; 2003 Feb 01; 9(2):729-37. PubMed ID: 12576442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]